Analytical techniques for material characterization
Scanning electron microscopy (SEM) was carried out with a Zeiss Supra 40 VP (Zeiss, Germany), equipped with a field emission gun (acceleration voltage 2 kV, working distance 3 mm). Samples were prepared by placing a droplet of a diluted aqueous [ZrO] 2+
[CLP] 2-IOH-NP suspension on a silica wafer that was left for drying overnight.
Energy-dispersive X-ray spectroscopy (EDXS) was performed with an Ametek EDAX device (Ametek, U.S.A.) mounted on the above described Zeiss SEM Supra 40 VP scanning electron microscope. For this purpose, the [ZrO] 2+
[CLP] 2-IOH-NPs were pressed to dense pellets in order to guarantee for a smooth surfaces and a quasi-infinite layer thickness. These pellets were fixed with conductive carbon pads on aluminum sample holders.
Fourier-transformed infrared (FT-IR) spectra were recorded on a Bruker Vertex 70 FT-IR
spectrometer (Bruker, Germany) in the range 4000-370 cm -1 with a resolution of 4 cm -1
. To this concern, 1 mg of dried [ZrO] 2+
[CLP] 2-IOH-NPs was pestled with 300 mg of KBr and pressed to a pellet, which thereafter was measured in transmission.
Differential thermal analysis/thermogravimetry (DTA/TG) was performed with a STA409C device
(Netzsch, Germany). The measurements were performed in air to guarantee for total organics combustion.
The vacuum dried [ZrO] 2+
[CLP] 2-IOH-NPs (20 mg in corundum crucibles) were heated to 1000 °C with a rate of 5 K/min.
Elemental analysis (C/H/N/S analysis) was performed via thermal combustion with an Elementar
Vario Microcube device (Elementar, Germany) at a temperature of 1100 °C. Figure 1b ).
Synthesis of [ZrO
-S3 - Figure S1 . Accordingly, the excitation can be performed at 500-700 nm with λ max = 655 nm. IOH-NPs -as expected -is identical to pure Dyomics-647 uridine triphosphate.
b) Size distribution
In addition to statistical evaluation of particles on SEM images, particle diameter and size distribution of the as-prepared [ZrO]
2+
[CLP] 2-IOH-NPs were also validated via DLS in water. As a result a mean hydrodynamic diameter of 73(14) nm was determined ( Figure S2 ). Such difference between the mean diameter of nanoparticles obtained by statistical evaluation of particles on SEM images and the mean hydrodynamic diameter obtained via DLS in aqueous suspension is not surprising. SEM, on the one hand,
shows the "real" particle diameter without any solvent shell and surface conditioning. The hydrodynamic diameter obtained via DLS, on the other hand, reflects the diameter in the presence of adsorbed solvent molecules. Due to the very high polarity of water, the rigid layer of adsorbed solvent molecules is often significantly expanded. Moreover, the nanoparticles are typically not agglomerated as such but the layers of adsorbed solvent molecules are merged so that the nanoparticles do not show independent diffusion.
As a result, DLS shows larger diameters. Such effect is again strongly supported by the high polarity of water and extensive hydrogen bonding. These effects of water as a solvent can be easily verified by redispersing IOH-NPs in a less polar but more coordinating solvent such as diethylene glycol [S1] . After redispersion of IOH-NPs in diethylene glycol, the size distribution curve is only slightly shifted in comparison to the size distribution curve obtained from electron microscopy. Diethylene glycol, however, is not the relevant solvent for biomedical application. Finally, it must be noted that the as-prepared
[CLP] 2-IOH-NPs do not contain any specific stabilizer (e.g., dextran, protamine, polyethylene glycol). Nevertheless, the IOH-NPs are colloidally stable and do not show precipitation over several weeks. Furthermore, the presence of zirconium and phosphorus was qualitatively proven by energy dispersive X-ray spectroscopy (EDXS).
To quantify the chemical composition of the [ZrO]
[CLP] 2-IOH-NPs, thermogravimetry (TG) was performed to verify the total organics content via thermal combustion ( Figure S3 ).
[ZrO]
[CLP] 2-shows more-or-less continuous decomposition in a temperature range of 100-1000 °C with a total weight loss of 66% (samples were dried at 100 °C) due to total combustion of the Figure S1 ). 
Biological studies a) Bacteria
The bacterial strain used in this study was S. aureus strain SH1000. Staphylococci were grown to the mid-log phase at 37 °C with shaking (150 rpm) in brain heart infusion (BHI) medium. Bacteria were collected by centrifugation, washed with sterile PBS, and diluted to the required concentration. The number of viable bacteria was determined after serial diluting and plating on blood-agar.
b) Generation of bone marrow derived macrophages
BMDM were isolated from 4-to 6-week-old C57BL/6 mice (Harlan Laboratories United Kingdom).
Briefly, mice were sacrificed by CO 2 asphyxiation. Femurs and tibias were removed and the bone marrow was harvested by repeated flushing with Iscove's modified Dulbecco's medium (DMEM). Bone marrow cells were incubated in DMEM supplemented with 10% FCS, 2 mM of L-glutamine, 1 mM of pyruvate, 100 U/mL of penicillin, 100 µg/mL of streptomycin, and 20 U/mL of recombinant murine M-CSF (BioLegend, San Diego, USA) for 6 days.
c) In vitro infection of bone marrow derived macrophages
BM-derived macrophages were infected with S. aureus at a multiplicity of infection (MOI) of 10:1 (10 bacteria per macrophage) and incubated for 1 h at 37 °C, 5% CO 2 . Macrophages were washed 2-times with sterile PBS, and some cells were then disrupted with dH 2 O to release intracellular bacteria, the -S7 -amount of viable intracellular bacteria was then calculated by platting serial dilutions on blood agar plates.
This was considered time 0 h relative to drug treatment and the amount of intracellular bacteria was referred to as 100%. The remaining cells were then exposed to [ZrO] 2+
[CLP] 2-IOH-NPs and free, dissolved clindamycin (50 µg/mL Na 2 (CLP)) at equal concentration in fresh cell culture medium and incubated further for the indicated time points at 37 °C, 5% CO 2 . These cells were then also disrupted with dH 2 O to release intracellular bacteria, and the amount of viable intracellular bacteria was calculated by plating on blood agar. This was considered time 4 h relative to drug treatment. For the generation of cell lysates, cells were treated as described above, washed twice with sterile PBS and lysed with 500 µL of sterile water. 
e) Transmission electron microscopy
Macrophages (10 6 /mL) were grown in Permanox® 4 well chamber slides overnight at 37 °C.
Subsequently, they were infected with S. aureus SH1000 (MOI 10:1). Accordingly, they were treated for 4, 6, and 12 hours with [ZrO]
2+
[CLP] 2-IOH-NPs, or they were untreated as a nanoparticle-free control.
Samples were prepared for embedment and ultrathin sectioning as it has been described in [S2] .
For electron energy-loss spectroscopy, 40 nm ultrathin sections were sectioned 'enface' and were picked up with neopren-coated 300 mesh Cu-grids. Unstained sections were analyzed with an integrated energy-filtered transmission electron microscope (EF-TEM; Zeiss Libra120plus; Zeiss, Oberkochen,
Germany) and spectra (parallel electron energy-loss spectroscopy, PEELS) as well as elemental maps (electron spectroscopic imaging, ESI) were recorded by a bottom-mounted, cooled 2048×2048 CCD camera (Sharp.Eye; Tröndle, Moorenwies, Germany). PEELS were recorded within an energy range from 90 eV to 350 eV with a chanel width of 0.112 eV ( Figure S4 ). ESI sequences have been recorded according to the 3-window method, with energy-windows set at 148, 172 and 211 eV with the energy-slit set to 10 eV energy width (main paper: Figure 3a,b) . The magnification applied ranged from nominally ×8000 to ×20000 at 120 kV. The illumination aperture was set to 0.63 to 0.80 mrad, with an emission current set to 1 µA to 4 µA. Data acquisition and evaluation were performed with the iTEM-System software (version 5.2, OSIS, Münster, Germany). 
g) Sample preparation and analysis of macrophage cell lysates
All cell lysate samples were analyzed via HPLC-MS/MS using an Agilent 1290 HPLC system equipped with a diode array UV detector and coupled to an AB Sciex QTrap 6500 mass spectrometer.
First, a calibration curve was prepared by spiking different concentrations of clindamycinphosphate (CLP) or clindamycin hydrochloride (CL) into macrophage cell lysate. The lower limits of quantification are indicated in Table S1 . Caffeine was used as an internal standard. In addition, quality control samples (QCs) were prepared for clindamycinphosphate and clindamycin hydrochloride in cell lysate. For clindamycinphosphate and clindamycin hydrochloride as well as for cell lysate samples the same extraction procedure was used: 10 µL of a sample (calibration samples, QCs or samples) was extracted with 20 µL of methanol containing 12.5 ng/mL of caffeine as internal standard for 10 min at 2000 rpm on an Eppendorf MixMate® vortex mixer. Then samples were spun down at 13.000 rpm for 5 min at 12 °C.
Supernatants were transferred to standard HPLC-glass vials. HPLC conditions were as follows: column:
Agilent Zorbax Eclipse Plus C18, 50×2.1 mm, 1.8 µm; temperature: 30 °C; injection volume: 1 µL; flow rate: 700 µL/min; solvent A: water +0.1% formic acid; solvent B: acetonitrile +0.1% formic acid; the same gradient was used for clindamycinphosphate and clindamycin hydrochloride: 99% A at 0 min, 99%-0% A from 0.1 min to 5.50 min, 0% A until 6.00 min, 0%-99% A from 6.00 min to 6.20 min, 99% A -S10 -until 8.00 min; UV detection: 190-400 nm. Mass spectrometric conditions were as follows: Scan type:
MRM, positive mode; Q1 and Q3 masses for caffeine, clindamycinphosphate and clindamycin hydrochloride can be found in Table S2 ; peak areas of each sample and of the corresponding internal standard were analyzed using MultiQuant 3.0 software (AB Sciex). Peak areas of the respective sample containing clindamycin hydrochloride or phosphate were normalized to the internal standard peak area. was used for quantification and m/z 195.116 → 110.000 was used for qualification. Peaks of samples were quantified using the calibration curve. The accuracy of the calibration curve was determined using
QCs independently prepared on different days (Table S1 ). Figure 5 ) and dissolved clindamycin hydrochloride (CL, Figure S6 ). The amount of intracellular clindamycin was determined in BMDM lysates by HPLC-MS/MS to determine the intracellular clindamycin levels.
-S11 - 
h) Statistics
Data were analyzed by using Excel 2016 (Microsoft Office) or GraphPad Prism 5.0 (GraphPad sofware). All data are presented as mean ±SD. Comparison between groups was made by use of T-test. P values ≤0.05 were considered as significant.
i) Determination of minimal inhibitory concentration (MIC)
To obtain the minimal inhibitory concentration (MIC) of CLP of the applied S. aureus strain, the bacteria were grown in a volume of 300 µL in a 96-well plate (Sarstedt, Germany) for 24 h in the absence or the presence of the indicated concentrations of antibiotics. Bacterial growth was then measured as absorbance at OD 600nm by using a TECAN Sunrise ® ELISA reader (Tecan Group, Switzerland) and transferred for better visualization to a heat map ( Figure S7 ). Accordingly, a MIC of <0.625 µg per mL Figure S9b ). This IOH-NP-related fluorescence was significantly increased upon incubation for 1 h with 50 µg/mL of IOH-NPs ( Figure S9c ).
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